Risultati della ricerca - P. Andrew Futreal
- Mostra 1 - 20 risultati su 249
- Vai alla pagina seguente
-
1
Understanding the target di Michael R. Stratton, P. Andrew Futreal
Pubblicazione 2004Artigo -
2
-
3
Breast cancer genome heterogeneity: a challenge to personalised medicine? di Charles Swanton, Rebecca A. Burrell, P. Andrew Futreal
Pubblicazione 2011Editorial -
4
An Alu polymorphism intragenic to the TP53 gene di P. Andrew Futreal, J. Carl Barrett, Roger W. Wiseman
Pubblicazione 1991Artigo -
5
The cancer genome di Michael R. Stratton, Peter J. Campbell, P. Andrew Futreal
Pubblicazione 2009Revisão -
6
Emerging patterns of somatic mutations in cancer di Ian R. Watson, Koichi Takahashi, P. Andrew Futreal, Lynda Chin
Pubblicazione 2013Revisão -
7
A survey of RNA editing in human brain di Matthew J. Blow, P. Andrew Futreal, Richard Wooster, Michael R. Stratton
Pubblicazione 2004Artigo -
8
Genetic screens using the piggyBac transposon di Su Kit Chew, Roland Rad, P. Andrew Futreal, Allan Bradley, Pentao Liu
Pubblicazione 2010Artigo -
9
Statistical Analysis of Pathogenicity of Somatic Mutations in Cancer di Chris Greenman, Richard Wooster, P. Andrew Futreal, Michael R. Stratton, Douglas F. Easton
Pubblicazione 2006Artigo -
10
-
11
Cancer and genomics di P. Andrew Futreal, Arek Kasprzyk, Ewan Birney, James C. Mullikin, Richard Wooster, Michael R. Stratton
Pubblicazione 2001Artigo -
12
MuSE: accounting for tumor heterogeneity using a sample-specific error model improves sensitivity and specificity in mutation calling from sequencing data di Yu Fan, Xi Liu, Daniel Hughes, Jianjun Zhang, Jianhua Zhang, P. Andrew Futreal, David A. Wheeler, Wenyi Wang
Pubblicazione 2016Artigo -
13
A census of human cancer genes di P. Andrew Futreal, Lachlan Coin, Mhairi Marshall, Thomas A. Down, Tim Hubbard, Richard Wooster, Nazneen Rahman, Michael R. Stratton
Pubblicazione 2004Revisão -
14
-
15
RNA editing of human microRNAs. di Matthew J. Blow, Russell J Grocock, Stijn van Dongen, Anton J. Enright, Ed Dicks, P. Andrew Futreal, Richard Wooster, Michael R. Stratton
Pubblicazione 2006Artigo -
16
Features of non-activation dendritic state and immune deficiency in blastic plasmacytoid dendritic cell neoplasm (BPDCN) di Hannah C. Beird, Maliha Khan, Rui Wang, Mansour Alfayez, Tianyu Cai, Li Zhao, Joseph D. Khoury, P. Andrew Futreal, Marina Konopleva, Naveen Pemmaraju
Pubblicazione 2019Artigo -
17
-
18
-
19
Identification of Double-stranded Genomic DNA Spanning All Chromosomes with Mutated KRAS and p53 DNA in the Serum Exosomes of Patients with Pancreatic Cancer di Christoph Kahlert, Sónia A. Melo, Alexei Protopopov, Jiabin Tang, Sahil Seth, Moritz Koch, Jianhua Zhang, Juergen Weitz, Lynda Chin, P. Andrew Futreal, Raghu Kalluri
Pubblicazione 2014Artigo -
20
LKB1/KRAS mutant lung cancers constitute a genetic subset of NSCLC with increased sensitivity to MAPK and mTOR signalling inhibition di Claire Mahoney, Bhudipa Choudhury, Helen Davies, Sarah Edkins, Chris Greenman, Gijs van Haaften, Tatiana Mironenko, Thomas Santarius, Claire Stevens, Michael R. Stratton, P. Andrew Futreal
Pubblicazione 2009Artigo
Strumenti per la ricerca:
Soggetti correlati
Biology
Genetics
Gene
Cancer
Cancer research
Medicine
Internal medicine
Mutation
Oncology
Computational biology
Genome
Immunology
Pathology
Immune system
Immunotherapy
Somatic cell
DNA
Germline mutation
Breast cancer
Gene expression
Lung cancer
Phenotype
Bioinformatics
Adenocarcinoma
DNA damage
Human genome
Chromosome
Exome sequencing
Immune checkpoint
Carcinogenesis